3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Phase 2
1
Status
Not yet recruiting
1
Completed
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Pathologic Complete Response
1
Colorectal Neoplasms
1
Interventions
Magnetic Resonance Spectroscopy
271
Specimen Handling
266
pembrolizumab
233
Cyclophosphamide
219
Radiotherapy
208
Nivolumab
169
Cisplatin
165
Biopsy
152
Carboplatin
145
Radiosurgery
131
fludarabine
125
Blood Specimen Collection
120
Gemcitabine
113
Paclitaxel
109
Surveys and Questionnaires
108
Standard of Care
106
venetoclax
97
Dexamethasone
95
Bevacizumab
93
Radiation
87
Rituximab
83
Capecitabine
81
Cytarabine
80
Oxaliplatin
77
Drug Therapy
76
Doxorubicin
75
Ipilimumab
74
durvalumab
73
fludarabine phosphate
70
atezolizumab
69
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
OTHER
×
FOLFOXIRI protocol
×
90 days
×
Clear all
NCT02350530
2026-05-22
FORBES
Sun Yat-sen University
Phase 2
Completed
138 enrolled
NCT07472868
2026-03-16
MEND-IT II
Catharina Ziekenhuis Eindhoven
Phase 3
Not yet recruiting
394 enrolled